An FDA panel is giving the green light for the Johnson & Johnson COVID-19 booster shot.

The panel unanimously decided to recommend the agency authorize the second J & J  dose for adults who have already gotten the first shot.

Reports say many FDA committee members recommend the vaccine be considered a two-dose vaccine, similar to Moderna and Pfizer.

This comes after studies show the single-dose J & J vaccine is less effective compared to the Pfizer and Moderna vaccines.

The World Health Organization remains opposed to giving any booster vaccines to people in wealthy countries, when more than half the world’s population has not even gotten one Covid-19 vaccine.


Photo by Alpha Media Portland OR